Literature DB >> 7774592

Loss of TAL-1 protein activity induces premature apoptosis of Jurkat leukemic T cells upon medium depletion.

K Leroy-Viard1, M A Vinit, N Lecointe, H Jouault, U Hibner, P H Roméo, D Mathieu-Mahul.   

Abstract

Transcriptional activation of the tal-1 gene occurs in -30% of patients with T cell Acute Lymphoblastic Leukemia and is therefore likely to be involved in human T cell leukemogenesis. However, the TAL-1 protein functional properties involved in this process have not been assessed so far. We have derived a clonal subline of the Jurkat T cell line which produced solely a mutant truncated form of TAL-1 protein. Sequencing of genomic DNA and cDNAs showed that the only transcribed tal-1 allele of this mutant subline harbored a G nucleotide insertion at codon 270. The resulting frameshift modifies TAL-1 residues 272-278 and creates a stop at codon 279. Although the deletion of the 53 carboxy-terminal residues of the TAL-1 protein did not directly affect the TAL-1 basic helix-loop-helix domain (residues 185-243), it had drastic effects on TAL-1 functional properties, since the mutant subline exhibited a dramatic decrease of protein binding activity to the TAL-1 DNA consensus sequence. Growth curves indicated that the mutant subline exhibited premature apoptosis upon medium depletion or serum reduction when compared with the parental cells. However, no difference between Jurkat and the mutant subline was observed in etoposide- or Fas/APO-1-triggered apoptosis. Stable expression of the mutant TAL-1 protein in Jurkat cells resulted in a phenotype that was similar to that of the mutant Jurkat subline, indicating that the TAL-1 mutant protein behaved like a dominant negative mutant and that the premature apoptosis of the mutant subline upon medium depletion was the consequence of the loss of TAL-1 protein activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7774592      PMCID: PMC398343          DOI: 10.1002/j.1460-2075.1995.tb07229.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  52 in total

1.  Effect of bcl-2 on Fas antigen-mediated cell death.

Authors:  N Itoh; Y Tsujimoto; S Nagata
Journal:  J Immunol       Date:  1993-07-15       Impact factor: 5.422

Review 2.  The LIM domain: a new structural motif found in zinc-finger-like proteins.

Authors:  I Sánchez-García; T H Rabbitts
Journal:  Trends Genet       Date:  1994-09       Impact factor: 11.639

3.  Clinical significance of TAL1 gene alteration in childhood T-cell acute lymphoblastic leukemia and lymphoma.

Authors:  A Kikuchi; Y Hayashi; S Kobayashi; R Hanada; K Moriwaki; K Yamamoto; J Fujimoto; Y Kaneko; S Yamamori
Journal:  Leukemia       Date:  1993-07       Impact factor: 11.528

Review 4.  Promotion and inhibition of activation-induced apoptosis in T-cell hybridomas by oncogenes and related signals.

Authors:  D R Green; A Mahboubi; W Nishioka; S Oja; F Echeverri; Y Shi; J Glynn; Y Yang; J Ashwell; R Bissonnette
Journal:  Immunol Rev       Date:  1994-12       Impact factor: 12.988

5.  Distinct DNase-I hypersensitive sites are associated with TAL-1 transcription in erythroid and T-cell lines.

Authors:  K Leroy-Viard; M A Vinit; N Lecointe; D Mathieu-Mahul; P H Roméo
Journal:  Blood       Date:  1994-12-01       Impact factor: 22.113

6.  scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice.

Authors:  L Robb; J E Rasko; M L Bath; A Strasser; C G Begley
Journal:  Oncogene       Date:  1995-01-05       Impact factor: 9.867

7.  Expression of TAL-1 proteins in human tissues.

Authors:  K Pulford; N Lecointe; K Leroy-Viard; M Jones; D Mathieu-Mahul; D Y Mason
Journal:  Blood       Date:  1995-02-01       Impact factor: 22.113

8.  Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia.

Authors:  P D Aplan; D P Lombardi; G H Reaman; H N Sather; G D Hammond; I R Kirsch
Journal:  Blood       Date:  1992-03-01       Impact factor: 22.113

9.  Regulation of G1 progression by E2A and Id helix-loop-helix proteins.

Authors:  F A Peverali; T Ramqvist; R Saffrich; R Pepperkok; M V Barone; L Philipson
Journal:  EMBO J       Date:  1994-09-15       Impact factor: 11.598

10.  Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia.

Authors:  I Wadman; J Li; R O Bash; A Forster; H Osada; T H Rabbitts; R Baer
Journal:  EMBO J       Date:  1994-10-17       Impact factor: 11.598

View more
  8 in total

1.  ETO2 coordinates cellular proliferation and differentiation during erythropoiesis.

Authors:  Nicolas Goardon; Julie A Lambert; Patrick Rodriguez; Philippe Nissaire; Sabine Herblot; Pierre Thibault; Dominique Dumenil; John Strouboulis; Paul-Henri Romeo; Trang Hoang
Journal:  EMBO J       Date:  2006-01-12       Impact factor: 11.598

2.  The SCL gene specifies haemangioblast development from early mesoderm.

Authors:  M Gering; A R Rodaway; B Göttgens; R K Patient; A R Green
Journal:  EMBO J       Date:  1998-07-15       Impact factor: 11.598

3.  Anti-apoptotic activity of low levels of wild-type p53.

Authors:  P Lassus; M Ferlin; J Piette; U Hibner
Journal:  EMBO J       Date:  1996-09-02       Impact factor: 11.598

4.  Genetic interaction between Kit and Scl.

Authors:  Julie Lacombe; Gorazd Krosl; Mathieu Tremblay; Bastien Gerby; Richard Martin; Peter D Aplan; Sebastien Lemieux; Trang Hoang
Journal:  Blood       Date:  2013-07-08       Impact factor: 22.113

5.  Erbb2 regulates inflammation and proliferation in the skin after ultraviolet irradiation.

Authors:  Justin G Madson; David T Lynch; Kelsey L Tinkum; Sumanth K Putta; Laura A Hansen
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

6.  Ectopic TAL-1/SCL expression in phenotypically normal or leukemic myeloid precursors: proliferative and antiapoptotic effects coupled with a differentiation blockade.

Authors:  G L Condorelli; A Tocci; R Botta; F Facchiano; U Testa; L Vitelli; M Valtieri; C M Croce; C Peschle
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

7.  Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis.

Authors:  M J Weiss; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

8.  Transcription factor SCL is required for c-kit expression and c-Kit function in hemopoietic cells.

Authors:  G Krosl; G He; M Lefrancois; F Charron; P H Roméo; P Jolicoeur; I R Kirsch; M Nemer; T Hoang
Journal:  J Exp Med       Date:  1998-08-03       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.